CAPPELLO JOSEPH (VP, Pharmaceutical Development) sold 3.1% of their position (10.26K shares) of GENELUX CORP on the open market
Open‑market sale worth $28.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/2/2026ACC: 0001493152-26-041285
Officer· VP, Pharmaceutical Development
Since Jan 2023
-10.26K
Net shares
Net seller
$28.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.26K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.26K
Price / share
$2.74
Trade value
$28.11K
% of position
3.1%
8/31/2026
328.74K→318.48K
Total
Net shares
−10.26K
Net value
-$28.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2026 | S · Sale | −10.26K | $2.74 | $28.11K | 3.1% | 328.74K | 318.48K |
| Total | −10.26K | -$28.11K | ||||||
Derivative Transactions0
No derivative transactions reported